321 related articles for article (PubMed ID: 22205677)
1. Breast and ovarian cancers: a survey and possible roles for the cell surface heparan sulfate proteoglycans.
Yoneda A; Lendorf ME; Couchman JR; Multhaupt HA
J Histochem Cytochem; 2012 Jan; 60(1):9-21. PubMed ID: 22205677
[TBL] [Abstract][Full Text] [Related]
2. Heparan Sulfate Proteoglycans Can Promote Opposite Effects on Adhesion and Directional Migration of Different Cancer Cells.
Depau L; Brunetti J; Falciani C; Mandarini E; Riolo G; Zanchi M; Karousou E; Passi A; Pini A; Bracci L
J Med Chem; 2020 Dec; 63(24):15997-16011. PubMed ID: 33284606
[TBL] [Abstract][Full Text] [Related]
3. Heparan sulfate proteoglycans in Drosophila neuromuscular development.
Kamimura K; Maeda N
Biochim Biophys Acta Gen Subj; 2017 Oct; 1861(10):2442-2446. PubMed ID: 28645846
[TBL] [Abstract][Full Text] [Related]
4. Prognostic impact of the glypican family of heparan sulfate proteoglycans on the survival of breast cancer patients.
Grillo PK; Győrffy B; Götte M
J Cancer Res Clin Oncol; 2021 Jul; 147(7):1937-1955. PubMed ID: 33742285
[TBL] [Abstract][Full Text] [Related]
5. Specific genes involved in synthesis and editing of heparan sulfate proteoglycans show altered expression patterns in breast cancer.
Fernández-Vega I; García O; Crespo A; Castañón S; Menéndez P; Astudillo A; Quirós LM
BMC Cancer; 2013 Jan; 13():24. PubMed ID: 23327652
[TBL] [Abstract][Full Text] [Related]
6. Cell surface heparan sulfate proteoglycans control adhesion and invasion of breast carcinoma cells.
Lim HC; Multhaupt HA; Couchman JR
Mol Cancer; 2015 Jan; 14(1):15. PubMed ID: 25623282
[TBL] [Abstract][Full Text] [Related]
7. Profiling heparan sulfate proteoglycans in ovarian carcinoma.
Clamp AR; Jayson GC
ScientificWorldJournal; 2005 Mar; 5():230-3. PubMed ID: 15798883
[No Abstract] [Full Text] [Related]
8. Distribution and clinical significance of heparan sulfate proteoglycans in ovarian cancer.
Davies EJ; Blackhall FH; Shanks JH; David G; McGown AT; Swindell R; Slade RJ; Martin-Hirsch P; Gallagher JT; Jayson GC
Clin Cancer Res; 2004 Aug; 10(15):5178-86. PubMed ID: 15297422
[TBL] [Abstract][Full Text] [Related]
9. Heparan sulfate proteoglycans in healthy and diseased systems.
Whitelock J; Melrose J
Wiley Interdiscip Rev Syst Biol Med; 2011; 3(6):739-51. PubMed ID: 21462353
[TBL] [Abstract][Full Text] [Related]
10. Heparan Sulfate Proteoglycans in Human Colorectal Cancer.
Vicente CM; da Silva DA; Sartorio PV; Silva TD; Saad SS; Nader HB; Forones NM; Toma L
Anal Cell Pathol (Amst); 2018; 2018():8389595. PubMed ID: 30027065
[TBL] [Abstract][Full Text] [Related]
11. Ovarian carcinoma cells synthesize both chondroitin sulfate and heparan sulfate cell surface proteoglycans that mediate cell adhesion to interstitial matrix.
Kokenyesi R
J Cell Biochem; 2001 Aug 1-9; 83(2):259-70. PubMed ID: 11573243
[TBL] [Abstract][Full Text] [Related]
12. Glypican-1 is overexpressed in human breast cancer and modulates the mitogenic effects of multiple heparin-binding growth factors in breast cancer cells.
Matsuda K; Maruyama H; Guo F; Kleeff J; Itakura J; Matsumoto Y; Lander AD; Korc M
Cancer Res; 2001 Jul; 61(14):5562-9. PubMed ID: 11454708
[TBL] [Abstract][Full Text] [Related]
13. The signaling mechanisms of syndecan heparan sulfate proteoglycans.
Lambaerts K; Wilcox-Adelman SA; Zimmermann P
Curr Opin Cell Biol; 2009 Oct; 21(5):662-9. PubMed ID: 19535238
[TBL] [Abstract][Full Text] [Related]
14. Functions of cell surface heparan sulfate proteoglycans.
Bernfield M; Götte M; Park PW; Reizes O; Fitzgerald ML; Lincecum J; Zako M
Annu Rev Biochem; 1999; 68():729-77. PubMed ID: 10872465
[TBL] [Abstract][Full Text] [Related]
15. Targeting heparan sulfate proteoglycans in breast cancer treatment.
Koo CY; Sen YP; Bay BH; Yip GW
Recent Pat Anticancer Drug Discov; 2008 Nov; 3(3):151-8. PubMed ID: 18991783
[TBL] [Abstract][Full Text] [Related]
16. Imatinib as a key inhibitor of the platelet-derived growth factor receptor mediated expression of cell surface heparan sulfate proteoglycans and functional properties of breast cancer cells.
Malavaki CJ; Roussidis AE; Gialeli C; Kletsas D; Tsegenidis T; Theocharis AD; Tzanakakis GN; Karamanos NK
FEBS J; 2013 May; 280(10):2477-89. PubMed ID: 23374223
[TBL] [Abstract][Full Text] [Related]
17. Sugar antennae for guidance signals: syndecans and glypicans integrate directional cues for navigating neurons.
Rhiner C; Hengartner MO
ScientificWorldJournal; 2006 Aug; 6():1024-36. PubMed ID: 16937008
[TBL] [Abstract][Full Text] [Related]
18. Proteoglycans and glycosaminoglycans as regulators of cancer stem cell function and therapeutic resistance.
Vitale D; Kumar Katakam S; Greve B; Jang B; Oh ES; Alaniz L; Götte M
FEBS J; 2019 Aug; 286(15):2870-2882. PubMed ID: 31230410
[TBL] [Abstract][Full Text] [Related]
19. DcR3 binds to ovarian cancer via heparan sulfate proteoglycans and modulates tumor cells response to platinum with corresponding alteration in the expression of BRCA1.
Connor JP; Felder M; Kapur A; Onujiogu N
BMC Cancer; 2012 May; 12():176. PubMed ID: 22583667
[TBL] [Abstract][Full Text] [Related]
20. Expression of heparan sulfate proteoglycans in murine models of experimental colitis.
Patterson AM; Delday MI; van Kuppevelt TH; Loh G; Blaut M; Haller D; Grant G; Kelly D
Inflamm Bowel Dis; 2012 Jun; 18(6):1112-26. PubMed ID: 21987406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
